BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34465341)

  • 1. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
    Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
    Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.
    Agaoglu NB; Unal B; Akgun Dogan O; Zolfagharian P; Sharifli P; Karakurt A; Can Senay B; Kizilboga T; Yildiz J; Dinler Doganay G; Doganay L
    Expert Rev Mol Diagn; 2022 Feb; 22(2):239-246. PubMed ID: 35240897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
    Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CNVs in NGS Data Using VS-CNV.
    Fortier N; Rudy G; Scherer A
    Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent count region-copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data.
    Kim MJ; Lee S; Yun H; Cho SI; Kim B; Lee JS; Chae JH; Sun C; Park SS; Seong MW
    Genet Med; 2022 Mar; 24(3):663-672. PubMed ID: 34906491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
    Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
    BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer.
    Moreno-Cabrera JM; Del Valle J; Feliubadaló L; Pineda M; González S; Campos O; Cuesta R; Brunet J; Serra E; Capellà G; Gel B; Lázaro C
    J Med Genet; 2022 Jan; 59(1):75-78. PubMed ID: 33219106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.
    Povysil G; Tzika A; Vogt J; Haunschmid V; Messiaen L; Zschocke J; Klambauer G; Hochreiter S; Wimmer K
    Hum Mutat; 2017 Jul; 38(7):889-897. PubMed ID: 28449315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRACNAC: A
    Kechin A; Boyarskikh U; Borobova V; Khrapov E; Subbotin S; Filipenko M
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
    Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
    Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel.
    Chiang T; Liu X; Wu TJ; Hu J; Sedlazeck FJ; White S; Schaid D; Andrade M; Jarvik GP; Crosslin D; Stanaway I; Carrell DS; Connolly JJ; Hakonarson H; Groopman EE; Gharavi AG; Fedotov A; Bi W; Leduc MS; Murdock DR; Jiang Y; Meng L; Eng CM; Wen S; Yang Y; Muzny DM; Boerwinkle E; Salerno W; Venner E; Gibbs RA
    Genet Med; 2019 Sep; 21(9):2135-2144. PubMed ID: 30890783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of copy number variation analysis for next-generation sequencing diagnostics.
    Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
    Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.